View our MACB Council Members to get to know them.

Get direction to our office.

Subscribe and be one of our MACB members now to get a great deal.

Published MACB Guidelines

Download Here

Description

KDIGO and NICE have since updated their guidelines. Based on KDIGO 2024 and NICE 2021 guidelines, the newly constituted MACB CKD Task Force has updated their recommendations on laboratory reporting of eGFR and urine albumin, as well as to include 5-year and 2-year predicted risk of progressing to end stage kidney disease (ESKD), calculated using the kidney failure risk equation (KFRE). KFRE-predicted risk will be included in blood reports when eGFR (Chronic Kidney Disease Epidemiology Collaboration, CKD-EPI) is less than 60 ml/min/1.73 m2 and where urine albumin to creatinine ratio (uACR) is measured. This will not only help predict who will have a high risk of progression to ESKD, but also to help identify individuals who need referral to nephrologists to modify the progression of kidney disease.

Read More Here

Corporate

Members:

Get in touch

Use our contact form for all information requests or contact us directly using the contact  button.

MACB

Afilliations: